Viral Hepatitis Flashcards

1
Q

Transaminases

A

-AST occurs in 2 isoenzymes (cytoplasmic and mitochondrial)
-Found in cardiac and skeletal muscle, kidney, pancreas and RBC
=Increase in alcoholic liver injury when ALT normal (ratio>2)

-ALT cytoplasmic
=Low concentration in muscle
=Usually, parallel rise and fall in liver disease
=Increases in HCV and fatty liver when AST normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alkaline phosphatase

A

-Zinc metalloenzymes
-Liver, bone and kidney – same gene but placenta and intestine different gene.
-Increase in last trimester to 2x ULN which may persist for a few weeks following delivery.
-Wheat-germ lectin affinity electrophoresis separates bone and liver isoenzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Glutamyl transferase

A

-Found in liver, kidney, pancreas, intestine and prostate (membrane bound)
-15% of those screened above “normal” levels (4% > 100)
-Activity is not increased in 1/3 of heavy drinkers without liver disease.
-A binge does not increase levels in “healthy” livers
-Levels drop after 2-5 weeks of stopping drinking
-Commonly increased with enzyme-inducing medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of viral hepatitis

A

-Common
=Hep A, B(+/- D), C, E

Less common
=Cytomegalovirus
=Epstein-Barr virus

-Rare
=Herpes simplex
=Yellow fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Hep A

A

-Enterovirus (picornavirus)
-RNA
-27nm
-2-4-week incubation
-Spread: faeces (faecal-oral), salvia
-Anti-HAV antibodies (IgM) in transient incubation period
-Vaccine/ passive prevention= immune serum globulin (IgG)- marker of previous infection
-No chronic carrier state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe Hep B

A

-Hepadnavirus
-DNA and DNA polymerase enzyme= Dane particle
-42nm
-Incubation 4-20 week
-Spread: Blood, saliva, sexual, vertical
-Chronic infection (6 months HBsAg), often asymptomatic
=HBsAg (Hep B surface antigen indicator of active infection)
=Hep B core IgM (recent infection)
-Vaccine, hyperimmune serum globulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe Hep C

A

-Flavivirus
-RNA
-30-38nm
-2-26-week incubation
-Spread: blood, saliva
-Chronic infection
-No prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical features of acute infection

A

-Non-specific prodromal illness
=Headache
=Myalgia
=Arthralgia
=Nausea
=Anorexia
=Jaundice
=Dark urine
=Dark stool

=Vomiting
=Diarrhoea
=Abdominal discomfort

-O/E
=Liver tender but only minimally enlarged
=Mild splenomegaly and cervical lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Complications of acute viral hepatitis

A

-Acute liver failure
-Cholestatic hepatitis (Hep A)
-Aplastic anaemia
-Chronic liver disease and cirrhosis (Hep B and C)
-Relapsing hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Investigations of viral hepatitis

A

-Hepatic LFTs
=Serum transaminases 200-2000 U/L in acute infection
=Plasma bilirubin reflects degree of liver damage
=ALP rarely exceeds twice the upper limit of normal

-Prolongation of PT indicates severity of hepatitis, rarely exceeds 25 seconds except in liver failure
-WCC normal with relative lymphocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Overall management of viral hepatitis

A

-Drugs such as sedatives and narcotics (metabolised in liver) should be avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Overall management of viral hepatitis

A

-Drugs such as sedatives and narcotics (metabolised in liver) should be avoided
-No alcohol during acute illness
-Elective surgery avoided in acute hepatitis as risk of post-operative liver failure
-Liver transplantation in complications of cirrhosis resulting from chronic hep B/C infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Source of hep B infection and risk of chronic infection

A

Horizontal transmission (10%)
* Injection drug use
* Infected unscreened blood products
* Tattoos/acupuncture needles
* Sexual transmission
* Close living quarters/playground play as a toddler (may contribute to high rate of horizontal transmission in Africa)
Vertical transmission (90%)
* Hepatitis B surface antigen (HBsAg)-positive mother (most common cause of infection worldwide, highest risk of chronic infection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why may the adaptive immune response to HBV be absent initially in vertical transmission of hep B?

A

-Introduction of antigen in neonatal period tolerogenic
-Presentation of such antigen within the liver promotes tolerance (absence of significant innate/ inflammatory response
-Very high loads of antigen may lead to exhaustion of cellular immune response
=May be reversed by therapy/ spontaneous changes in innate response (IFN-a, NK), host-mediated immunopathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the 5 phases of chronic HBV infection

A
  1. Immune-tolerant phase
    =High viral load so very infectious, normal/ low ALT
  2. Immune-reactive HBeAg +ve chronic hepatitis phase
    =Raised ALT, mod/severe necroinflammation
  3. Inactive carrier phase
    =Normal ALT, normal/ minimal necroinflammation
  4. HBeAg -ve chronic hepatitis phase
    =Fluctuating viral load, raised/ fluctuating ALT, mod/severe necroinflammation
  5. HBsAg -ve phase
    =Normal viral load and ALT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of acute hepatitis B

A

-Supportive with monitoring for acute liver failure
-5-10% develop chronic hep B infection, also common in immunodeficient individuals
-Recovery= antibody to viral antigens, chronic= HBeAg

16
Q

Management of chronic hep B

A

-Goals: HBeAg seroconversion, reduction in HBV-DNA, normalisation of LFT
-Oral antiviral agents more effective in reducing viral loads in patients with e negative than e positive as viral loads lower
=Direct-acting nucleoside/ nucleotide analogues
=Pegylated interferon alpha

17
Q

Describe direct-acting nucleoside/ nucleotide antiviral agents

A

-Orally administered
-Inhibit reverse transcription of pre-genomic RNA to HBV-DNA by HBV-DNA polymerase
-Relapse common if treatment withdrawn as cccDNA not directly affected
=Potential for antiviral-resistant mutations with long-term treatment

18
Q

Describe interferon-a

A

-Most effective in patients with low viral load and serum transaminases greater than x2 upper limit of normal (augments native immune response)
-Contraindicated in cirrhosis (causes rise in serum transaminases and precipitates liver failure)
-Side effects= fatigue, depression, irritability, bone marrow suppression, triggers autoimmune thyroid disease

19
Q

Liver transplantation in hep B

A

-Post-liver transplant prophylaxis with direct- acting antiviral agents and hep B immunoglobulins